Literature DB >> 6831403

Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213.

R S Gupta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831403

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

1.  Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids.

Authors:  B S Glisson; A M Killary; P Merta; W E Ross; J Siciliano; M J Siciliano
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

3.  Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.

Authors:  D Roberts; T Lee; E Parganas; L Wiggins; J Yalowich; R Ashmun
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline.

Authors:  J P Eder; B A Teicher; S A Holden; L Senator; K N Cathcart; L E Schnipper
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.

Authors:  M J Robinson; B A Martin; T D Gootz; P R McGuirk; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 6.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

7.  Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.

Authors:  P B Jensen; H Roed; M Sehested; E J Demant; L Vindeløv; I J Christensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.

Authors:  S Merry; S B Kaye; R I Freshney
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

9.  Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.

Authors:  M K Ritke; D Roberts; W P Allan; J Raymond; V V Bergoltz; J C Yalowich
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

10.  Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line.

Authors:  R S Gupta; W Murray; R Gupta
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.